Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides

被引:16
作者
de Haan, EC
Wagenaar-Hilbers, JPA
Liskamp, RMJ
Moret, EE
Wauben, MHM
机构
[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Med Chem, NL-3508 TB Utrecht, Netherlands
[2] Univ Utrecht, Dept Infect Dis & Immunol, Div Immunol, NL-3508 TD Utrecht, Netherlands
关键词
antigen presentation; autoimmunity; major histocompatibility complex; MHC; peptide modification; specificity; T cell receptor; TCR;
D O I
10.1016/j.molimm.2004.07.044
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The balance between specific and degenerate T cell recognition of MHC class II bound peptides is crucial for T cell repertoire selection. and holds important implications for protective immunity versus autoimmunity. To investigate the degree of degeneracy in T cell recognition we applied selected modifications to T cell receptor (TCR) contact residue amino acids in the MHC class II bound epitope gpMBP72-85. By using glycosylated amino acids, as an example of a posttranslational modification, large alterations were applied. Small modifications were accomplished by exchanging an arginine residue for a citrulline or an ornithine residue. Finally. the unmodified TCR contact residue side chains were shifted one atom position to the left, using peptoid residues. Both these large and subtle changes in the wild type (WT) peptide caused lack of recognition by WT peptide specific monoclonal and polyclonal T cells. Furthermore. T cells specific for the modified peptides did not cross recognize the WT peptide. Using a set of additional compounds. we investigated the specificity of these T cell populations into detail. Our data reveal a strongly limited plasticity in T cell recognition. and a high specificity for TCR contact residue side chains. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:355 / 364
页数:10
相关论文
共 52 条
[1]   Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis [J].
Bäcklund, J ;
Carlsen, S ;
Höger, T ;
Holm, B ;
Fugger, L ;
Kihlberg, J ;
Burkhardt, H ;
Holmdahl, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) :9960-9965
[2]   THE RAPID ISOLATION OF CLONABLE ANTIGEN-SPECIFIC LYMPHOCYTE-T LINES CAPABLE OF MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS [J].
BENNUN, A ;
WEKERLE, H ;
COHEN, IR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (03) :195-199
[3]   Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand [J].
Bielekova, B ;
Goodwin, B ;
Richert, N ;
Cortese, I ;
Kondo, T ;
Afshar, G ;
Gran, B ;
Eaton, J ;
Antel, J ;
Frank, JA ;
McFarland, HF ;
Martin, R .
NATURE MEDICINE, 2000, 6 (10) :1167-1175
[4]  
Cao LG, 1999, BIOCHEMISTRY-US, V38, P6157
[5]   SELECTION OF ENCEPHALITOGENIC RAT LYMPHOCYTE-T CLONES RECOGNIZING AN IMMUNODOMINANT EPITOPE ON MYELIN BASIC-PROTEIN [J].
CHOU, YK ;
VANDENBARK, AA ;
JONES, RE ;
HASHIM, G ;
OFFNER, H .
JOURNAL OF NEUROSCIENCE RESEARCH, 1989, 22 (02) :181-187
[6]  
Corthay A, 1998, EUR J IMMUNOL, V28, P2580, DOI 10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO
[7]  
2-X
[8]   Stabilization of peptide guinea pig myelin basic protein 72-85 by N-terminal acetylation-implications for immunological studies [J].
de Haan, EC ;
Wauben, MHM ;
Wagenaar-Hilbers, JPA ;
Grosfeld-Stulemeyer, MC ;
Rijkers, DTS ;
Moret, EE ;
Liskamp, RMJ .
MOLECULAR IMMUNOLOGY, 2004, 40 (13) :943-948
[9]   Structure-based design and evaluation of MHC class II binding peptides [J].
de Haan, EC ;
Wauben, MHM ;
Grosfeld-Stulemeyer, MC ;
Moret, EE .
BIOLOGICALS, 2001, 29 (3-4) :289-292
[10]   Major histocompatibility complex class II binding characteristics of peptoid-peptide hybrids [J].
de Haan, EC ;
Wauben, MHM ;
Grosfeld-Stulemeyer, MC ;
Kruijtzer, JAW ;
Liskamp, RMJ ;
Moret, EE .
BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (06) :1939-1945